| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.03 |